363
Views
0
CrossRef citations to date
0
Altmetric
Errata

Errata

This article refers to:
Safety and efficacy outcomes of long-term treatment up to 4 years with 5% lidocaine medicated plaster in patients with post-herpetic neuralgia

Correction to: Sabatowski R, Hans G, Tacken I et al. Safety and efficacy outcomes of long-term treatment up to 4 years with 5% lidocaine medicated plaster in patients with post-herpetic neuralgia. Curr Med Res Opin 2012;28:1337-46.

The authors have been made aware of errors in , and of the above paper on the use of 5% lidocaine medicated plaster. In and , which depict the Clinical Global Impression of Change and the Patients’ Global Impression of Change, the numbers of patients displayed above the 30 month, 36 month, 42 month and 48 month columns should have read 56, 43, 38 and 27, respectively. The corrected figures are displayed below.

Figure 4. Clinical Global Impression of Change. Evolution over time.

Figure 4. Clinical Global Impression of Change. Evolution over time.

Figure 5. Patients’ Global Impression of Change. ‘Minimally/not improved’ summarizes the PGIC categories ‘minimally improved’, ‘no change’, ‘minimally worse’, ‘much worse’ and ‘very much worse’.

Figure 5. Patients’ Global Impression of Change. ‘Minimally/not improved’ summarizes the PGIC categories ‘minimally improved’, ‘no change’, ‘minimally worse’, ‘much worse’ and ‘very much worse’.

Figure 6. Global evaluation of the 5% lidocaine medicated plaster by clinicians and patients at final visits.

Figure 6. Global evaluation of the 5% lidocaine medicated plaster by clinicians and patients at final visits.

In the ‘Patients’ column of , the total number should have been 76, and the numbers for the ‘Excellent’ and ‘Very good’ categories should have been 15 and 30, respectively. This results in slight changes of the percentages and presented bars of the ‘Patients’ column. The corrected is displayed below.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.